Canandaigua National Trust of Florida’s AstraZeneca AZN Stock Holding History

Canandaigua National Trust of Florida’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$891K	Buy	+5,473	New	+$912K	0.49%	52
2026 Q1	–	Sell	-5,547	Closed	-$1.02M	–	112
2025 Q4	$1.02M	Buy	5,547 +297	+6%	+$52.1K	0.64%	34
2025 Q3	$806K	Sell	5,250 -363	-6%	-$54.9K	0.64%	39
2025 Q2	$784K	Buy	5,613 +3,415	+155%	+$479K	0.56%	47
2025 Q1	$323K	Buy	2,198 +110	+5%	+$15.9K	0.28%	82
2024 Q4	$274K	Sell	2,088 -1,486	-42%	-$208K	0.21%	100
2024 Q3	$557K	Buy	+3,574	New	+$577K	0.48%	52

Other funds holding AZN

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $837M AUM 20.44% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

PNC

Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return

CCM

Cox Capital Management Andover, Massachusetts $179M AUM 28.94% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CNBT

Canandaigua National Bank & Trust Canandaigua, New York $1.15B AUM

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return

Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Canandaigua National Trust of Florida's AZN Position: Q3 2026 in Review

Canandaigua National Trust of Florida opened a new position in AstraZeneca (AZN) in Q3 2026: 5,473 shares worth $891K. The stake represents 0.49% of the portfolio and ranks #52 among its holdings. This is a return to the name: Canandaigua National Trust of Florida previously reported a position in AZN as recently as Q4 2025.

Canandaigua National Trust of Florida first reported a position in AZN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.02M in Q4 2025. 47 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

Canandaigua National Trust of Florida held 5,473 shares of AstraZeneca worth $891K as of Q3 2026.
AstraZeneca was a new Canandaigua National Trust of Florida position in Q3 2026.
AstraZeneca made up 0.49% of Canandaigua National Trust of Florida's portfolio in Q3 2026, its #52 holding.
Canandaigua National Trust of Florida first reported a position in AstraZeneca in Q3 2024 and has held it in 7 quarters since.
Canandaigua National Trust of Florida's AstraZeneca position peaked at $1.02M in Q4 2025.
47 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q3 2026, filed 7 Oct 2026.